Pfizer
This is a stock which I like, it does seem to be a classic value stock. A large dividend, and lots of room for sustained growth, but is it a value trap?

A few items come to mind about PFE, one is alot of people have abandoned this stock, the stock seems to be left for dead due to a corporate mentality of pushing for big drugs that will deliver huge profits, a strategy which failed.

What seems more import is a term more commonly associated with Internet marketing, and that is the fat tail or long tail. The concept is relying less on blockbusters and more on sales of a larger repertoire of drugs and this is one that PFE has. I have read that PFE has 200 drugs in the pipeline, none are likely to be blockbusters but in aggregate the sales could add up.